Filing Details

Accession Number:
0001567619-21-016001
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-17 17:02:49
Reporting Period:
2021-08-13
Accepted Time:
2021-08-17 17:02:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1556270 Jay Jonathan Mazelsky One Idexx Drive
Westbrook ME 04092
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-13 3,417 $675.34 52,010 No 4 S Direct
Common Stock Disposition 2021-08-13 983 $676.38 51,027 No 4 S Direct
Common Stock Disposition 2021-08-13 337 $677.58 50,690 No 4 S Direct
Common Stock Disposition 2021-08-16 533 $672.36 50,157 No 4 S Direct
Common Stock Disposition 2021-08-16 488 $673.69 49,669 No 4 S Direct
Common Stock Disposition 2021-08-16 182 $674.48 49,487 No 4 S Direct
Common Stock Disposition 2021-08-16 60 $675.44 49,427 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average price of the shares sold ranging from a low of $675.00 to a high of $675.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average price of the shares sold ranging from a low of $676.01 to a high of $676.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  3. Represents the weighted average price of the shares sold ranging from a low of $677.13 to a high of $677.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  4. Represents the weighted average price of the shares sold ranging from a low of $672.08 to a high of $673.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  5. Represents the weighted average price of the shares sold ranging from a low of $673.13 to a high of $674.07 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  6. Represents the weighted average price of the shares sold ranging from a low of $674.16 to a high of $674.91 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  7. Represents the weighted average price of the shares sold ranging from a low of $675.29 to a high of $675.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.